DESTINIE STONE: Open Payments
NPI 1619625647 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 10 payments from 9 companies in 2025. Trend: 2023 $32 · 2024 $374 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1 | $175 |
| Insulet Corporation | 1 | $145 |
| Dexcom, Inc. | 1 | $143 |
| Amgen Inc. | 1 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $102 |
| Enterra Medical, Inc. | 1 | $101 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: MAKO, OMNIPOD, Dexcom G6 Transmitter, EVENITY, GATTEX, JOURNAVX, Exparel, BRIDION.
Industry payments across TX — which companies pay providers there.
